Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Income After Tax (2009 - 2016)

Updated

Kazia Therapeutics (KZIA) reported Income After Tax of -$13.42 million for FY2025 (year ended Jun 30, 2025).

Analysis

Kazia Therapeutics (KZIA) Income After Tax (2009 - 2016) Analysis & Trends

Dating back to FY2009, Kazia Therapeutics' Income After Tax record includes 17 fiscal years.

  • The FY2025 figure ranks as the highest annual Income After Tax since FY2021.
  • According to Business Quant data, Income After Tax came in at -$18.03 million in FY2024, -$13.96 million in FY2023, -$17.9 million in FY2022 and -$10.52 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income After Tax (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 210.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 4.22 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.80 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 3.25 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -9.12 Mn
Dec 31, 2015 -5.26 Mn
Dec 31, 2014 -6.47 Mn
Dec 31, 2013 -1.40 Mn
Aug 30, 2013 -5.22 Mn
Dec 31, 2012 -1.52 Mn
Dec 31, 2011 15.11 Mn
Dec 31, 2010 16.70 Mn
Dec 31, 2009 15.44 Mn
API Access

Kazia Therapeutics Income After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=KZIA&period=max&api_key=YOUR_API_KEY